ClinicalTrials.Veeva

Menu

Epidemiology of Hepatitis B, C and Delta in Reunion Island (HEPEPID)

C

Centre Hospitalier Universitaire de la Réunion

Status

Unknown

Conditions

Hepatitis D
Hepatitis C
Hepatitis B

Study type

Observational

Funder types

Other

Identifiers

NCT03362866
2016/CHU/14

Details and patient eligibility

About

Viral hepatitis B, C and Δ represent a global public health problem for which France was very early mobilized. Despite this, in its foreword, the Dhumeaux report on "Management of people infected with hepatitis B or hepatitis C viruses" identifies a residual area of weakness in this care that is the incomplete regional epidemiological data in the Overseas Territories. The specific ethno-socio-cultural characteristics of these territories make it difficult to transpose data from the mainland France. This study aims at improving our knowledge on the characteristics of patients with hepatitis B, C and Δ in Reunion Island, their follow-up, their evolution and complications.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Major patient

  • with confirmed HBsAg and / or anti HCV positive Ab
  • residing in Reunion Island
  • followed in one of the participating centers

Exclusion criteria

• Patient carrying isolated anti HBc antibodies

Trial contacts and locations

0

Loading...

Central trial contact

Olivier Maillard, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems